Library
All documents
Benchmarking the Livestock Business Environment - Mrs. Edna Kallon - World Bank, USA
VICH 5 Session 4: Voice of Industries
Statement of principle for VICH the "3R" approach & Alternatives to Animal Testing - Dr. Nicholas Jarrett - EU/VICH EU coordinator
VICH 5 Session 5: Contribution to animal welfare in tests for VMPs
Waiver of Target Animal Batch Safety Test - Dr. Marlies Halder - EU/Topic leader for TABST in the BQM EWG
VICH 5 Session 5: Contribution to animal welfare in tests for VMPs
The VICH pharmacovigilance guidelines - Dr. Margarita Brown - FDA
VICH 5 Session 6: VICH NOW
Bioequivalence - Dr. Marilyn Martinez - FDA
VICH 5 Session 6: VICH NOW
Development of a VICH guideline on stability studies to address climatic zones III and IV - Dr. Alice Sigobodhla - Department of Health, South Africa
VICH 5 Session 7: Topics of particular interest for Observer Countries and VOF members
New VICH guideline on the efficacy studies for combination products - Dr. Ken Noda - JMAFF
VICH 5 Session 7: Topics of particular interest for Observer Countries and VOF members
New VICH guideline on residue studies in aquatic species - Dr. Pamela Boner - Zoetis/Topic leader for aquatic species in the MRK EWG
VICH 5 Session 7: Topics of particular interest for Observer Countries and VOF members
Outcome of the HealthforAnimals 2015 Global Animal Health Conference - Dr. Bettye Walters - Center for Veterinary Medicine, U.S. FDA
VICH 5 Session 8: Ongoing Activities: Global Perspectives